Abstract

SILVA-AYCAGUER, Luis Carlos  and  BLOCH-SILVA, Andrés. Reflexiones acerca de las cambiantes narrativas sobre las vacunas contra la covid-19. Rev. Fac. Nac. Salud Pública [online]. 2022, vol.40, n.3, e07.  Epub May 31, 2023. ISSN 0120-386X.  https://doi.org/10.17533/udea.rfnsp.e349338.

We set out to discern to what extent the media strategies adopted around the vaccines against covid-19 during the first 15 months since the beginning of their application can be considered as a legitimate and coherent contributions to a better understanding about their performance and to what extent the elaborated discourses could respond to the economic interests of the corporations’ elites. Once the most relevant elements that have shaped the predominant narratives from the moment the vaccines were conceived were compiled, several anomalies were identified that were to a greater or lesser extent invisibilized in the process of their approval and the results of their application. The most significant of these concern the handling of definitions, non-compliance with commitments and conflicts of interest that compromise the actions of vaccine marketing companies and regulatory bodies. Many elements related to corporative interests have influenced the narrative concerning vaccines. Among those that require a resignification are: their real preventive capacity against contagions, serious diseases and deaths, their efficacy against new variants, the duration of the immunity they confer, their side effects, the synergic role of acquired immunity, and the resources used by the companies to achieve a virtually market monopolistic predominance.

Keywords : COVID-19 vaccines; Efficacy; Controlled clinical trial; Conflict of interest; Marketing.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )